Pathogenesis of viral haemorrhagic fevers is associated with alteration of vascular barrier function and haemorrhage. To date, the specific mechanism behind this is unknown. Programmed cell death and regulation of apoptosis in response to viral infection is an important factor for host or virus survival but this has not been well-studied in the case of Crimean-Congo hemorrhagic fever virus (CCHFV). In this study, we demonstrated that CCHFV infection suppresses cleavage of poly(ADP-ribose) polymerase (PARP), triggered by staurosporine early post-infection. We also demonstrated that CCHFV infection suppresses activation of caspase-3 and caspase-9. Most interestingly, we found that CCHFV N can suppress induction of apoptosis by Bax and inhibit the release of cytochrome c from the inner membrane of mitochondria to cytosol. However, CCHFV infection induces activation of Bid late post-infection, suggesting activation of extrinsic apoptotic signalling. Consistently, supernatant from cells stimulated late post-infection was found to induce PARP cleavage, most probably through the TNF-a death receptor pathway. In summary, we found that CCHFV has strategies to interplay with apoptosis pathways and thereby regulate caspase cascades. We suggest that CCHFV suppresses caspase activation at early stages of the CCHFV replication cycle, which perhaps benefits the establishment of infection. Furthermore, we suggest that the host cellular response at late stages post-infection induces host cellular pro-apoptotic molecules through the death receptor pathway.
INTRODUCTION
Crimean-Congo hemorrhagic fever virus (CCHFV) is a member of the genus Nairovirus of the family Bunyaviridae. CCHFV is found worldwide (Asia, Africa, the Middle East, Europe) and causes severe disease in humans, with a reported mortality rate of up to 30 %. CCHFV is transmitted through tick bites or through contact with viraemic blood or tissues from patients or livestock. Viruses within this family encode three negative-sense ssRNA segments. The large (L) segment encodes the RNA-dependent RNA polymerase, the medium (M) segment codes for the two mature structural glycoproteins (Gn and Gc) and the small (S) segment encodes the nucleocapsid protein (N) (Elliott, 1990; Ergonul et al., 2006) .
The pathogenesis of viral haemorrhagic fevers (VHF) is associated with alteration of vascular barrier function and haemorrhage, most probably due to a combination of factors such as damage to the epithelium, consumption and degradation of clotting factors and an overactive inflammatory response. The reduced capacity or dysfunction of endothelial cells observed in CCHF cases is believed to be due to virus-mediated host factors such as the proinflammatory response, to the virus infection itself, or a combination of both. Therefore, a hyperactive host response may be important in progression of the disease. Cell death might contribute to the increased permeability of the vascular system and bleeding disorders observed among CCHFV patients. Clinical studies indicate that high viraemia is correlated with high cytokine levels and disease severity (Bray, 2005; Schnittler & Feldmann, 2003; Weber & Mirazimi, 2008) .
We have previously demonstrated that CCHFV can induce cleavage of poly(ADP-ribose) polymerase (PARP), which is associated with apoptosis and has been cited as one hallmark of apoptosis and caspase activation at late post-infection (Karlberg et al., 2011) . Rodrigues et al. (2012) subsequently showed that apoptosis is induced in human hepatoma cells at late stages of CCHFV infection.
Caspase-dependent apoptosis occurs following the activation of two main pathways initiated by both internal (intrinsic/ mitochondria-dependent pathway) and external stimuli (extrinsic/death receptor-mediated pathway). Caspases (cysteine aspartate-specific proteases) are activated and amplify apoptotic signalling pathways, leading to cell death. Effector caspases, including caspases-3, -6, and -7, and their activation are controlled by upstream initiator caspases such as caspases-8 and -9. Extrinsic and intrinsic pathways may function separately or mediate a crosstalk interconnection through cleavage of pro-apoptotic Bid, a member of the BCL-2 family of cell death regulators, which finally ends with cell death (Thornberry, 1998; . Pro-inflammatory host-derived mediators may contribute to receptormediated apoptosis in response to viral infection. External stimuli activate death receptors including TNFR, Fas/CD95 and TRAIL, which function to induce apoptosis. Upon binding of their ligands, these receptors become activated and initiate activation of caspase-8, which in turn activates Bid.
The intrinsic, or mitochondrial, pathway is associated with the release of mitochondrial proteins such as cytochrome c, which activate downstream caspase activity through activation of caspase-9, from the intermembrane space into the cytoplasm (Thornberry, 1998; . Intracellular processes can result in loss of mitochondrial integrity via pro-apototic members of the BCL-2 superfamily, such as Bid, Bak and Bax, which act directly on the outer mitochondrial membrane, facilitating secretion of mitochondria proteins ).
The aims of this study were to determine whether CCHFV regulates apoptosis pathways and to investigate the mechanism behind the regulatory properties of CCHFV, which interferes with the apoptotic signalling chain during the viral replication cycle.
RESULTS

CCHFV replication suppresses activation of caspase-3 and caspase-9
We have previously demonstrated that CCHFV infection induces caspase-3 activation at late stages post-infection in SW-13 (Karlberg et al., 2011) . In order to investigate the events early in the CCHFV replication cycle, in the present study, mock-or CCHFV-infected SW-13 cells [m.o.i. of 1 at 24 h post-infection (h p.i.)] were treated with different concentrations of STS, a relatively non-selective protein kinase inhibitor, which is often used as a general method for inducing apoptosis. At 5 h post-treatment, detached cells were harvested and analysed by Western blot. It was found that cleavage of PARP was clearly suppressed in the CCHFV-infected cells, compared with the mock-infected cells, in the 4 mM STS treatment (Fig. 1a, b) . However, at the highest concentration of STS used, no inhibition of PARP cleavage within infected cells was observed.
To investigate whether CCHFV infection regulates caspase-3 activation during STS treatment, SW13 cells were infected and treated as described above (with 4 mM STS) and analysed for the presence of caspase-3 cleavage. It was found that the activation of caspase-3 in the CCHFVinfected cells was significantly reduced compared with the mock-infected cells (Fig. 2a, b) . To further characterize the interaction of CCHFV replication and the apoptosis pathway, we analysed these samples for STS-induced cleavage of caspase-9, which is upstream of caspase-3. The results showed that cleavage of caspase-9 was also suppressed during the early phase of the CCHFV replication cycle in STS-treated infected cells, in contrast to mockinfected cells (Fig. 2c, d ). 
CCHFV infection suppresses release of cytochrome c in apoptotic cells
In order to investigate whether CCHFV infection interferes or interplays with release of cytochrome c from inner mitochondrial membrane in apoptotic cells caused by STS, mock-infected and CCHFV-infected cells (24 h p.i.) were not treated or treated with STS. Attached and detached cells were harvested at 5 h post-treatment, and the cytosol and mitochondria fractions were collected separately (Gogvadze et al., 2003) and analysed for estimated release of cytochrome c by Western blot. It was found that release of cytochrome c into the cytosol was reduced in infected cells compared with mockinfected cells, for both attached and detached cells (Fig. 3 ).
CCHFV N protein suppresses activation of apoptosis by Bax
Release of proteins, such as cytochrome c, from the mitochondrial intermembrane space to cytosol is controlled by BCL-2 pro-apoptotic members such as Bax. To investigate whether the CCHFV N protein is involved in or contributes to regulation of mitochondrial membrane permeabilization and downstream caspase activation, we established an in vitro system. The SW13 cells were transfected with a plasmid coding for CCHFV ORF N (myc-N), at different concentrations, and a plasmid coding for Bax (flagBax), a potent inducer of apoptosis that acts via the mitochondria. Induction of apoptosis in the presence and absence of CCHFV N was then analysed by measuring the activation of caspase-3. The results showed that overexpression of Bax (with a flag epitope at the N terminus) in SW13 cells induced a high level of apoptosis, as determined by the activation of caspase-3 and cleavage of endogenous PARP, when compared with mock-transfected cells (Fig. 4) . However, the level of apoptosis induced by Bax was significantly reduced when Bax was co-expressed with different amounts of recombinant N protein. These results suggest that expression of N in the early phase of CCHFV infection may suppress the apoptotic processes that are coordinated by Bax or downstream of Bax, and cause the CCHFV-infected cells to become resistant to apoptosis.
Pro-inflammatory cytokines released during CCHFV infection can induce PARP cleavage
As demonstrated above, we have evidence that at 24 h p.i., CCHFV has the ability to suppress caspase-3 activation through inhibition of release of cytochrome c by interfering with Bax This finding seems to contradict our previous observation that CCHFV infection induces apoptosis at late stages post-infection (Karlberg et al., 2011) . To investigate whether CCHFV infection initiates apoptotic signalling pathways through the extrinsic pathway at late post-infection, SW13 were mock-or CCHFV-infected (m.o.i. of 1). At 24 and 48 h p.i., cells were harvested and analysed for activation and cleavage of Bid (truncated Bid, tBid), which is a pro-apoptotic member of the BCL-2 family, by Western blot. External stimuli such as pro-inflammatory factors (TNF-a) activate the extrinsic or death receptor signalling pathways, which in turn activate caspase-8, leading to activation of Bid. Our results clearly demonstrated that CCHFV infection at late post-infection led to cleavage of Bid to tBid, in attached and detached cells (Fig. 5 ).
It has been demonstrated, by us and others (Karlberg et al., 2011; Rodrigues et al., 2012) , that CCHFV infection induces secretion of TNF-a and other pro-inflammatory factors at late stages post-infection, through activation of dendritic cells and macrophages. In the present study we examined whether the supernatant of infected SW13 cells contains pro-inflammatory factors, such as TNF-a, during infection, using SW13 cells which were mock-infected or CCHFV-infected (m.o.i. of 1) and harvested at 24, 48 and 72 h p.i. Analysis of supernatants for the presence of TNFa showed that infected cells secreted TNF-a at late stages post-infection (data not shown). However, to confirm whether induction of the cleavage of PARP at late postinfection is due to an extrinsic pathway, all supernatants, mock-and CCHFV-infected, were UV-inactivated in order to inactivate the virus (which may be present in the supernatant) and then transferred to seeded new SW13 cells for 24 h. The presence of CCHFV N, as an indicator of inactivation with UV and cleavage of PARP, was determined by Western blot for all lysates (data not shown). The results showed clearly that activation and cleavage of PARP were induced in cells to which supernatant from infected cells collected at either 48 or 72 h p.i. was added (Fig. 6a, b) . In contrast, no PARP cleavage was observed for cells incubated with supernatant from mock-infected or UVinactivated virus-infected cells.
In order to characterize the process in more detail, supernatants collected at 48 h p.i. from infected cells were mock treated or treated with neutralizing TNF-a antibodies (5 mg ml
21
) for 1 h at 37 u C and transferred to seeded SW13 cells. At 24 h post-treatment, detached cells were harvested and analysed by Western blot. The analysis showed that antibodies against TNF-a significantly suppressed cleavage of PARP (Fig. 6c) , indicating that TNF-a secreted from infected cells is a contributor to induction of the extrinsic apoptotic pathway during the late phase of infection.
DISCUSSION
A characteristic of Crimean-Congo haemorrhagic fever and other VHFs is loss of epithelium cell function, in particular function of endothelial cells, which leads to changes in vascular permeability and dysfunction, and imbalanced fluid distribution between the intra-and extra-vascular tissue space, causing coagulation disorders, haemorrhage and multi-organ failure (Peters & Zaki, 2002) .
Recently, two animal models with defective interferon responses, IFNAR 2 and STAT1 2 mice, which are killed by/ susceptible to CCHFV infection, have been used to study the pathogenesis of the disease (Bente et al., 2010; Bereczky et al., 2010) . Infected mice developed leukopenia, thrombocytopenia, and elevated levels of liver enzymes. The highest levels of CCHF vRNA were detected mainly in liver and spleen. These organs were clearly affected, with visible symptoms such as necrosis of the liver and massive lymphocyte depletion of the spleen. Infected mice also had elevated levels of pro-inflammatory cytokines (TNF-a, IL-6, IL-10) in serum/blood samples (Bente et al., 2010; Bereczky et al., 2010 ). An overstimulated host protective response might be one factor which contributes to coagulation disturbances, with haemorrhage and the overall vascular system affected.
In previous studies, we and others revealed that caspasedependent apoptotic pathways are induced in different human cell types late during the CCHFV replication cycle (Fraisier et al., 2014; Karlberg et al., 2011; Rodrigues et al., 2012) . Activation of executor caspase-3 then leads to cleavage of the viral structural protein, N. We found that caspase activation does not favour progeny viral production, and therefore suggested that it is induced by the host cell as a protective response, rather than being induced by the viral infection (Karlberg et al., 2011) . Viruses have different strategies to interfere with cell death pathways during infection to secure efficient progeny viral production, by expressing viral proteins (encode gene products) or down-/upregulating cellular pro-and anti-apoptotic proteins, which interfere with apoptotic signalling pathways. Rift Valley fever virus, a member of the family Bunyaviridae, encodes an NSm protein which has anti-apoptotic functions via inhibiting caspase-3 activity and upstream initiator caspases (Won et al., 2007) . Another member of the family Bunyaviridae, La Crosse virus, induces increased levels of cellular BCL-2 during infection, both in vivo and in vitro, which prolongs cell survival and seems to be important in decreasing apoptosis and preventing tissue damage (Pekosz et al., 1996) .
In the present study, where SW13 cells were used as a model system, we demonstrated that apoptotic signalling pathways are regulated early during the CCHFV replication cycle. By challenging CCHFV-infected cells at 24 h p.i. with STS, we were able to show that activation both upstream and on the executor caspase level (caspase-9 and caspase-3) was suppressed. In keeping with these results, we also showed that activation and cleavage of PARP, a marker of apoptosis, were suppressed.
Opening of the mitochondrial permeability transition pore and loss of membrane potential leads to release of proapoptotic proteins such as cytochrome c from the intermembrane space into the cytosol of cells undergoing apoptosis ). The released cytochrome c and Apaf-1 form a complex known as the apoptosome, leading to caspase-9 activation, which further activates downstream effector caspases . In the present study, we showed that secretion of cytochrome c from the mitochondria into the cytosol was decreased in STS-treated CCHFV-infected cells, but not in STS-treated mock-infected cells. This indicates that the release of mitochondrial proteins is regulated, and that caspase activation downstream of the mitochondrial level, including caspase-3, is suppressed or delayed during the early (a) A CaspACE fluorometric assay system was used to measure the activation of caspase-3 in SW13 cells that were mock transfected or transfected with CCHFV N only, or Bax in the absence or presence of CCHFV N. DNA used in each of the transfections is indicated in micrograms on the x-axis. In each transfection, the total amount of DNA was normalized to 1.8 mg with the addition of empty vector if necessary. All experiments were performed in triplicate, and means with SD are plotted. (b) Western blot analysis also was performed to determine the cleavage of endogenous PARP (top row). Similarly, the expression levels of the different proteins were determined using anti-FLAG or anti-Myc antibodies (middle rows). The amounts of total cell lysates loaded were verified by measuring the levels of endogenous actin (bottom row). Significance level: P,0.05 (*).
phase of CCHFV infection. It has previously been demonstrated that hepatitis C virus (HCV) encodes proteins with anti-apoptotic activity, which interfere with apoptosis signalling pathways by different mechanisms. HCV NS2 interferes with caspase-dependent induced apoptosis by counteracting cytochrome c release from mitochondria, which contributes to viral persistence by interfering with host cell defence (Erdtmann et al., 2003) . In the mitochondrial pathway, pro-apoptotic members of the BCL-2 superfamily are associated with the mitochondria and with release of cytochrome c. Bax is one of the key pro-apoptotic (BCL-2 member) molecules, an inactive monomer, and is normally found in the cytosol or loosely bound to the mitochondrial membrane. Upon activation by apoptotic stimuli, Bax changes conformation and forms oligomers, which are then integrated by formation of membrane pores that facilitate release of mitochondrial proteins such as cytochrome c, which leads to downstream caspase activation (Antonsson et al., 2000; Wolter et al., 1997) . By using a recombinant expression system, we showed that the overexpression of viral structural nucleocapsid (N) could inhibit Bax-induced apoptosis. These results indicate that the high level of CCHFV N expressed in infected cells has the ability to protect against apoptotic stimuli by acting at the level of Bax or downstream of it. Hence, N could be one of the major factors controlling cell death in the early phase of infection. It has recently been demonstrated that rubella virus capsid protein interferes with import of Bax into mitochondria and thereby prevents mitochondrial membrane permeabilization and promotes cell survival, and that adenovirus induces expression of anti-apoptotic protein E1B 19K (vBcl-2), which inhibits the TNF-a-mediated death signalling pathway, including release of mitochondrial proteins such as cytochrome c by directly interacting with Bax (Ilkow et al., 2011; Sundararajan et al., 2001) . It has also been reported that Hantaan virus nucleocapsid protein modulates apoptosis pathways through NFkB (Ontiveros et al., 2010) .
As discussed above, we have evidence that at 24 h p.i., CCHFV infection is able to inhibit caspase-3 activation through regulation of cytochrome c release by interplaying or interfering with Bax. This finding can be interpreted as contradicting our previous finding that CCHFV infection induces apoptosis at late post-infection (Karlberg et al., 2011) . External stimuli signalling through the death receptor pathway might initially induce caspase activation, triggered by the viral infection, and this often results in crosstalk between the extrinsic and intrinsic cell death pathways through the pro-apoptotic BCL-2 family member Bid, thereby facilitating induction of the mitochondrial pathway (Luo et al., 1998; Perez & White, 2000) . Transmissible gastroenteritis virus infection induces both the FasL and mitochondrial pathways, through interconnection with Bid and upregulation of Bid (Ontiveros et al., 2010) .
In the present study, we clearly demonstrated that Bid is active at late stages post-infection, and also that the supernatant of CCHFV-infected cells contains pro-inflammatory factors. These findings together indicate that CCHFV, at late stages post-infection, most probably induces apoptosis through induction of pro-inflammatory factors, which in turn activates the extrinsic apoptotic pathway. This assumption is in line with the data in Fig. 6(a, b) , which show that UV-inactivated supernatants, collected from CCHFVinfected cells at 48 and 72 h p.i., can induce cleavage of PARP in fresh cells from as early as 24 h post-treatment. Since all the supernatants collected were UV-inactivated before being transferred to the fresh cells, apoptosis could not have been induced by viral replication. Instead, it was most likely caused by pro-inflammatory mediators released into the medium as a cellular protective response to infection. This suggests in turn that caspase activation is triggered by external stimuli as a secondary effect. In the present study, we also demonstrated that neutralizing TNF-a antibodies reduced the cleavage of PARP triggered by supernatant from infected SW13 cells at 48 h p.i. (Fig. 6c) . However, the neutralization was not complete, which is most probably because we could not neutralize all TNF-a, or because other molecules are also involved in triggering the extrinsic pathway.
Hepatitis C virus induces apoptosis by an indirect immunologically mediated mechanism, and viral core protein enhances this process through TNF signalling pathways (Zhu et al., 1998) . Cytokines and chemokines regulate the host immune response, but might contribute to toxic effects when present in high concentrations. Dysregulation of the cytokine and chemokine response is anticipated to cause capillary fragility, leading to leakage of erythrocytes and plasma through the vascular endothelium and resulting in dangerous hypotension, which is a prominent feature of VHF (Geisbert & Jahrling, 2004) . Previous studies have shown that key molecules in CCHF progression seem to be cytokines such as IL-6, IL-8 and TNF-a. In an animal model, mice lacking STAT-1 had elevated IL-6, IL-10 and TNF-a concentrations, confirming findings in some severe human cases (Bente et al., 2010; Ergonul et al., 2006; Papa et al., 2006) .
In summary, this study showed that CCHFV has strategies to interplay with apoptotic molecular signalling pathways and thereby regulatory properties. It also showed that CCHFV N possesses the function of suppressing mitochondrial permeability through Bax, which in turn has an influence on downstream executor caspase activity. This delays or suppresses induced caspase activation during the early phase of the CCHFV replication cycle. This event perhaps works to the benefit of the virus, helping or allowing it to establish infection. In later phases of CCHFV infection, we suggest that the host cellular response may induce the death receptor pathway, leading to activation of Bid. However, this hypothesis should be followed up in future experiments.
METHODS
Cells, antibodies, chemicals and viruses. SW13 cells (human adrenal cortex adenocarcinoma cells) were maintained in Leibovitz's medium (L15; Life Technologies) supplemented with 2 % FBS and antibiotics (10 U penicillin ml 21 and 10 mg streptomycin ml 21 ). The antibodies used in this study included a rabbit polyclonal anti-CCHFV nucleocapsid antibody (Andersson et al., 2004) . Anti-Myc monoclonal (Santa Cruz Biotechnology), anti-actin monoclonal, anti-FLAG polyclonal (Sigma), anti-PARP polyclonal, anti-caspase-3, -9 monoclonal (Cell Signaling Technology), anti-cytochrome c and anti-TNF-a antibodies, recombinant TNF-a (rTNF-a) (BD Pharmingen) and staurosporine (STS) (Cell Signaling Technology) were used according to the manufacturer's instructions. HRP-conjugated antibodies (Pierce or Bio-Rad) were used, again according to the manufacturers' instructions. The CCHFV Ibar10200-strain, originally isolated in Nigeria, was used in the experiments and all handling of live virus was performed in a BSL-4 facility.
UV inactivation. Harvested cell supernatant was centrifuged for 10 min and irradiated at 254 nm (UVG-54), in order to inactivate viral particles. SW13 cells were infected with CCHFV, mock infected or treated with UV-inactivated virus. At different times post-infection (24, 48 and 72 h p.i.), supernatants were harvested and UV inactivated. These supernatants were then transferred to new SW13 cells seeded in sixwell plates. At 24 h p.i., cells were collected and analysed for cleavage of PARP in the absence of replicating virus.
Cytosolic and mitochondrial cytochrome c analysis. In order to analyse the release of cytochrome c from mitochondria, SW13 cells were seeded in six-well plates and either infected with CCHFV (m.o.i. of 1) or not infected. At 24 h p.i., the cells were incubated with apoptotic stimulus (0.1 mM STS) overnight at 37 uC, and attached and detached cells were harvested separately, centrifuged for 5 min washed with ice-cold PBS, and centrifuged a second time. The pellets were resuspended in a solution containing 0.15 M KCl, 5 mM Tris, 1 mM MgCl 2 and 0.01 % digitonin, incubated on ice for 20 min, and thereafter centrifuged at 10 min Cytosol and mitochondria fractions (Gogvadze et al., 2003) of mock and infected cells, detached and attached, were harvested and analysed by Western blot with anticytochrome c antibodies.
Transient transfections and CaspACE fluorometric assay.
Transient transfections of SW13 cells were performed using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's protocol. Expression plasmids for N with N-terminal Myc-tag and Bax with N-terminal FLAG-tag were previously constructed (Karlberg et al., 2011; Mohd-Ismail et al., 2009) . Approximately 24 h after transfection, the cells were harvested by scraping them into the medium, spun down in a bench-top centrifuge, and washed twice with cold PBS. The cell pellets were then resuspended in RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 0.5 % NP-40, 0.5 % deoxycholic acid, 0.005 % SDS and 1 mM phenylmethylsulfonyl fluoride) and subjected to freeze-thawing five times before being centrifuged to remove cellular debris. The cell lysate was then analysed by Western blot, and the activation of caspase-3 was quantified using the CaspACE fluorimetric assay system (Promega).
SDS-PAGE and Western blot analysis. Samples were resuspended in reducing sample buffer (10 mM Tris/HCl, 0.5 % SDS, 10 % glycerol; 2 % b-mercaptoethenol, bromophenol blue), boiled for 5 min and separated by SDS-PAGE using pre-cast gels (Life Technologies). Electrophoresis was carried out at 200 V and proteins were transferred to nitrocellulose membranes using a transfer buffer containing 25 mM Tris, 192 mM glycine and 20 % methanol at 100 V for 1 h. Membranes were blocked in 5 % non-fat dry milk overnight at 4 uC. After washing in PBS containing 0.01 % Tween (PBST), the membranes were incubated with primary antibody for 1 h at room temperature or overnight at 4 uC. The membranes were then washed with PBST before addition of secondary antibody. After incubation at room temperature for 1 h, the membranes were washed in PBST. Proteins were detected with ECL Plus Western blotting detection reagents (Amersham Pharmacia) according to the manufacturer's instructions. The intensity of bands was analysed within the linear range of the detector. The percentage of cleaved products was assessed by comparison with the total density of product (cleaved and uncleaved) in each well. The mean of three independent experiments was analysed (see statistical analysis).
Measurement of pro-inflammatory mediators. Supernatants from infected SW13 cells (m.o.i. of 1) were collected at 24, 48 and 72 h p.i., centrifuged at 13 000 r.p.m. for 10 min, and assayed for different cytokines and chemokines according to the manufacturer's instructions (Qiagen Mix-N-Match Multi-Analyte ElisaArray kit).
Neutralizing assay. SW13 were infected with CCHFV, mock infected, or treated with UV-inactivated virus. Supernatants were harvested 48 h p.i., centrifuged at 13 000 r.p.m. for 10 min, and UV inactivated. The supernatants and rTNF-a suspension (2 ng ml 21 ) were pre-incubated separately with or without neutralizing antibody against TNF-a (5 mg ml
21
) for 1 h at 37 uC and subsequently transferred to seeded SW13 and incubated for 24 h. All material was analysed by Western blot for PARP activation.
Densitometric and statistical analysis. Densitometric analysis was performing on Western blot results using quantitative software to determine the intensity of each band. Each band (cleavage products and uncleaved product) was correlated with the total amount of each protein, PARP, caspase-3, etc., which could then be used for statistical analysis. An unpaired Student's t-test was applied to evaluate the statistical significance of differences measured from the datasets, with P,0.05 considered statistically significant.
